---
title: "Agilent Technologies Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278943284.md"
description: "Agilent Technologies Inc. shares fell 3.28% to $111.63, marking the third consecutive day of losses amid a broader market decline, with the S&P 500 down 1.52%. The stock is 30.35% below its 52-week high of $160.27. In comparison, competitors like Thermo Fisher, Danaher, and Abbott also experienced declines, with trading volume at 2.2 million, slightly below the 50-day average of 2.3 million."
datetime: "2026-03-12T20:57:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278943284.md)
  - [en](https://longbridge.com/en/news/278943284.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278943284.md)
---

# Agilent Technologies Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Agilent Technologies Inc. (A) slid 3.28% to $111.63 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.52% to 6,672.62 and Dow Jones Industrial Average falling 1.56% to 46,677.85.

This was the stock's third consecutive day of losses.

Agilent Technologies Inc. closed 30.35% short of its 52-week high of $160.27, which the company reached on November 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Thermo Fisher Scientific Inc. (TMO) fell 4.00% to $475.89, Danaher Corp. (DHR) fell 4.51% to $186.26, and Abbott Laboratories (ABT) fell 1.91% to $108.14.

Trading volume (2.2 M) remained 85,022 below its 50-day average volume of 2.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

03-12-26 1657ET

### Related Stocks

- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Thermo Fisher Scientific and Precision Health Research Singapore Enter Strategic Collaboration to Advance Precise-SG100K Study](https://longbridge.com/en/news/282231224.md)
- [Is Thermo Fisher (TMO) Quietly Rewiring Its AI Strategy Through New Data and Proteomics Alliances?](https://longbridge.com/en/news/282768343.md)
- [Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes | DHR Stock News](https://longbridge.com/en/news/282498659.md)
- [Sterile Filtration Module Market Outlook 2026-2036: Biologics Expansion Drives USD 5.2 Billion Opportunity](https://longbridge.com/en/news/282611487.md)
- [Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says](https://longbridge.com/en/news/282275755.md)